Table 6

Adverse events of special interest possibly/probably related to COVID-19 vaccination among patient with inflammatory RMDs

AE typeSeriousness of AEOutcome of AECOVID-19 vaccineRMDRMD medication*Medication held or reduced
Cardiovascular – arterial hypertensionNon-seriousRecovered/resolved without sequelaeModernaaxSpATNFiNo
Non-seriousRecovered/resolved without sequelaeAZRAHCQ+GCNo
Non-seriousRecovered/resolved without sequelaePfizerRAMTX+GCNo
Serious (important medical event)Recovered/resolved without sequelaePfizerpSpAGCNo
Cardiac – arrhythmiaNon-seriousRecovered/resolved without sequelaePfizerSLEHCQ+AZA+GCNo
Non-seriousUNKPfizerRAGCYes
Non-seriousOngoing/continuingPfizerEDSNoneNA
Cardiac – coronary artery diseaseSerious (life threatening)Recovered/resolved without sequelaePfizerRAABA+MTX+GCNo
Serious (life threatening)Recovered/resolved with sequelaePfizerRARTX+LEF+GCNo
Cardiac – myocarditis and pericarditisNon-seriousRecovered/resolved without sequelaePfizerSLENoneNA
Dermatological – eczema, nodes and plaquesNon-seriousRecovered/resolved without sequelaePfizerRAABANo
Non-seriousRecovered/resolved without sequelaeModernaSjSHCQ+GCYes
Non-seriousOngoing/continuingAZPsAApremilastNo
Non-seriousRecovered/resolved without sequelaePfizerpSpATNFiNo
Dermatological – pruritus, injection site reaction, redness and burningNon-seriousRecovered/resolved without sequelaePfizerpSpALEF+GCNo
Non-seriousOngoing/continuingPfizerRAMTX+GCNo
Non-seriousRecovered/resolved without sequelaePfizerPMRHCQ+GCNo
Gastrointestinal – liver injuryNon-seriousRecovered/resolved without sequelaePfizerGCAMTXYes
Non-seriousOngoing/continuingPfizerRPAZA+GCNo
Serious (life threatening)Recovered/resolved with sequelaePfizerSLEHCQ+GCNo
General conditions – hot flush, anxiety, lowered body temperature, loss and lack of appetite and night sweatsNon-seriousRecovered/resolved without sequelaePfizerSScMMF+GCNo
Non-seriousRecovered/resolved without sequelaeAZaxSpATNFiNo
Non-seriousRecovered/resolved without sequelaePfizerRAIL-6UNK
Non-seriousRecovered/resolved without sequelaePfizerPsAIL-17Yes
Non-seriousRecovered/resolved without sequelaePfizerGCANoneNA
Non-seriousRecovered/resolved without sequelaeAZRAABA+MTXNo
Non-seriousRecovered/resolved without sequelaeModernaRANoneNA
Non-seriousOngoing/continuingAZaxSpATNFiNo
Haematological – peripheral deep vein thrombosisNon-seriousOngoing/continuingPfizeraxSpAIL-17No
Serious (hospitalisation)Ongoing/continuingPfizerAAVAZA+GCNo
Haematological – haemorrhagic diseaseNon-seriousRecovered/resolved without sequelaeAZRAHCQ+GCNo
Haematological – strokeSerious (Hospitalisation)Recovered/resolved with sequelaePfizerPMRIL-6+GCNo
Haematological – thrombocytopeniaNon-seriousRecovered/resolved without sequelaeAZmCTDNoneNA
Immunological – anaphylaxisNon-seriousRecovered/resolved without sequelaePfizerRAMTXNo
Non-seriousRecovered/resolved without sequelaePfizerSScSildenafilNo
Non-seriousRecovered/resolved without sequelaeAZOther vasculitisGCYes
Immunological – arthritisNon-seriousRecovered/resolved without sequelaeAZSjSHCQNo
Non-seriousRecovered/resolved without sequelaePfizerPMRHCQ+GCNo
Non-seriousUNKAZGCAIL-6+GCNo
Non-seriousRecovered/resolved without sequelaePfizerSLEHCQ+BelimumabNo
Immunological – skin or mucosalNon-seriousRecovered/resolved without sequelaePfizerSLEAZA+GCNo
Non-seriousRecovered/resolved without sequelaePfizeraxSpASSZ+GC+NSAIDsNo
Non-seriousRecovered/resolved without sequelaePfizerMyositisHCQ+MTX+GCNo
Non-seriousOngoing/continuingModernaSjSNoneNA
Serious (hospitalisation)Recovered/resolved without sequelaePfizerPsANoneNA
Serious (important medical event)Recovered/resolved without sequelaePfizerRAABA+HCQNo
Serious (important medical event)Recovered/resolved without sequelaeAZu-CTDHCQNo
Serious (important medical event)Ongoing/continuingPfizerPsATNFiNo
Immunological – vasculitidesNon-seriousRecovered/resolved without sequelaePfizerPsAIL-17Yes
LymphadenopathyNon-seriousRecovered/resolved without sequelaePfizerPsAIL-17+MTXNo
Non-seriousRecovered/resolved without sequelaeModernamCTDNoneNA
Non-seriousRecovered/resolved without sequelaePfizerOther vasculitisNoneNA
Non-seriousOngoing/continuingPfizerRAMTXNo
Malaise, fatigue and insomniaNon-seriousRecovered/resolved without sequelaeAZPMRMTX+GCNo
Non-seriousRecovered/resolved with sequelaeAZMonogenic AISColchicineNo
Serious (important medical event)Ongoing/continuingPfizerSScMMFYes
UNKUNKPfizerPsANoneNA
UNKUNKPfizerPsATNFi+NSAIDsNo
Neurological – anosmia and ageusiaNon-seriousRecovered/resolved without sequelaePfizerSjSMTXNo
Neurological – drowsiness, vertigo, dizziness, nausea, tinnitus, migraine, hallucination and hemiparesisNon-seriousOngoing/continuingPfizerSarcoidosisHCQNo
Non-seriousRecovered/resolved without sequelaeUnknownOther IAHCQ+GCNo
Non-seriousRecovered/resolved without sequelaePfizerpSpAApremilastNo
Non-seriousRecovered/resolved without sequelaeAZpSpAIL-17No
Non-seriousRecovered/resolved without sequelaePfizerPsAIL-17No
Non-seriousRecovered/resolved without sequelaePfizeraxSpAIL-17No
Non-seriousRecovered/resolved without sequelaePfizerSjSMTXNo
Non-seriousRecovered/resolved without sequelaePfizerPsAMTXNo
Non-seriousRecovered/resolved without sequelaeModernaRASSZNo
Non-seriousRecovered/resolved without sequelaePfizeraxSpATNFiNo
Non-seriousRecovered/resolved without sequelaePfizerNon-systemic JIATNFiNo
Non-seriousRecovered/resolved without sequelaePfizeraxSpATNFiNo
Non-seriousRecovered/resolved without sequelaePfizerPsATNFiNo
Non-seriousRecovered/resolved without sequelaePfizeraxSpATNFiYes
Non-seriousRecovered/resolved without sequelaeModernapSpANoneNA
Non-seriousRecovered/resolved without sequelaePfizerPsAIL-12/23No
Non-seriousOngoing/continuingAZPsANoneNA
Non-seriousRecovered/resolved without sequelaeAZRASSZNo
Non-seriousRecovered/resolved without sequelaePfizerRAMTXYes
Non-seriousRecovered/resolved without sequelaePfizerSScUnknownNA
Serious (important medical event)Ongoing/continuingPfizerSScHCQ+MMFNo (HCQ), UNK (MMF)
Other possible cardiac symptoms – ankle oedema, dyspnoea and dry coughNon-seriousRecovered/resolved without sequelaePfizerPsAIL-17No
Non-seriousRecovered/resolved without sequelaeModernaRAIL-6No
Non-seriousRecovered/resolved with sequelaePfizerAAVBenralizumabNo
Non-seriousOngoing/continuingModernaRARTX+GCNo
Non-seriousRecovered/resolved without sequelaePfizerRAJAKi +GCYes (GC), No (JAKi)
Serious (important medical event)Recovered/resolved without sequelaePfizerSjSHCQNo
UNKUNKPfizerRATNFiNo
Pain/pain syndromesNon-seriousUNKPfizerSjSNoneNA
Non-seriousRecovered/resolved without sequelaePfizerPMRGCUNK
Tendons and joints – tendinopathy, frozen shoulder and carpal tunnel syndromeNon-seriousUNKPfizerRAABA+MTXNo
Non-seriousOngoing/continuingModernauCTDNoneNA
Non-seriousOngoing/continuingPfizerPMRGCNo
UNKUNKAZRAMTXNo
Viral infections – herpes, herpes zoster and shinglesNon-seriousOngoing/continuingPfizerSjSHCQNo
Non-seriousOngoing/continuingModernaRAJAKiNo
Non-seriousOngoing/continuingPfizerRAJAKiNo
Non-seriousRecovered/resolved without sequelaePfizeraxSpATNFiNo
Non-seriousOngoing/continuingPfizerPMRGCNo
Non-seriousRecovered/resolved with sequelaeAZRATNFiNo
Serious (hospitalisation)Recovered/resolved without sequelaePfizerRAJAKiYes
Serious (hospitalisation)UNKPfizerRAMTX+GCYes (MTX), No (GC)
Serious (important medical event)Recovered/resolved without sequelaePfizerRAMTX+GCNo
Viral infections – influenza, flu-like episodes, rhinitis, cough and coldNon-seriousRecovered/resolved without sequelaePfizer+AZGCAIL-6No
Non-seriousRecovered/resolved without sequelaePfizerMyositisMTXNo
Non-seriousRecovered/resolved without sequelaePfizerRAMTXNo
Non-seriousRecovered/resolved without sequelaePfizerRARTX+MTXNo
Non-seriousRecovered/resolved without sequelaePfizeraxSpATNFiNo
Non-seriousRecovered/resolved without sequelaePfizerCRMOTNFi+MTXNo
Non-seriousRecovered/resolved without sequelaePfizerSjSNoneNA
Other – GORDNon-seriousRecovered/resolved without sequelaePfizerRALEFNo
Other – neck swellingSerious (hospitalisation)Recovered/resolved without sequelaePfizerRALEFNo
Other (UNK)Non-seriousUNKPfizerRAJAKi+LEF+GCNo
  • *Immunosuppressive or immunomodulatory medication.

  • AAV, ANCA-associated vasculitis; ABA, abatacept; AE, adverse event; AIS, autoinflammatory syndrome; axSpA, axial spondyloarthritis; AZ, Oxford/AstraZeneca; AZA, azathioprine; CRMO, chronic recurrent multifocal osteomyelitis; EDS, Ehlers-Danlos syndrome; GC, glucocorticoids; GCA, giant cell arteritis; GORD, gastro-oesophageal reflux disease; HCQ, hydroxychloroquine; IA, inflammatory arthritis; IL-6, interleukin-6; IL-17, interleukin-17; IL-12/23, interleukin-12/23; JAKi, Janus kinase inhibitors; JIA, juvenile idiopathic arthritis; LEF, leflunomide; mCTD, mixed connective tissue disease; MMF, mycophenolate mofetil/mycophenolic acid; MTX, methotrexate; NSAIDs, nonsteroidal anti-inflammatory drugs; PMR, polymyalgia rheumatica; PsA, psoriatic arthritis; pSpA, peripheral spondyloarthritis; RA, rheumatoid arthritis; RMD, rheumatic and musculoskeletal disease; RP, relapsing polychondritis; RTX, rituximab; SjS, Sjogren’s syndrome; SLE, systemic lupus erythematosus; SpA, spondyloarthritis; SSc, systemic sclerosis; SSZ, sulfasalazine; TNFi, tumour necrosis factor; uCTD, undifferentiated connective tissue disease; UNK, unknown/missing.